PDC line Pharma NV
PDC line Pharma (NV) is a company in Liège, active in research and experimental development on natural sciences and engineering, founded in 2016, with 22 employees (full-time equivalents). Financial year 2024: gross margin €2.9m, profit -€11.01m, equity -€7.8m.
2 warnings: negative equity, in liquidation1 serious, 1 point of attentionShowHide
- Explained →
Negative equity. Equity was € -7,801,066 in financial year 2024. Debts exceed what the company owns; the board must in principle follow the alarm bell procedure.
Source: NBB, 2024 annual accounts - View in the CBE ↗
In liquidation. Legal situation according to the CBE: Vrijwillige ontbinding – vereffening.
Source: CBE
Figures for PDC line Pharma, 2024NBB · abridged format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2024. The sector is recalculated every night.
See everything about PDC line Pharma
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2024 filed
- Annual accounts 2023 filed
- Incorporated as naamloze vennootschap
Activities NACE-BEL 2025
Establishments 1
- Boulevard de Patience et Beaujonc 3, 4000 Liège · since 01/07/20232.342.153.783
AuditProSanctions and politically exposed persons
Is a director on a sanctions list, or do they share the name of a politically exposed person? You can see it with Nummo Pro. Start your free trial
Publications in the Belgian Official Gazette 23 publications
- 04/12/2025Registered officeSiege socialDeed (pdf)
- 26/08/2025BoardDissolution and mergerFin (cessation, annulation cessation, nullite, conc, reorganisation judiciaire, etc...), demissions, nominationsDeed (pdf)
- 21/06/2024BoardDemissions, nominationsDeed (pdf)
All 23 publications → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more